Novartis announced in a press release today that it has made the first batch of vaccine against influenza A ( H1N1) flu causing the swine flu pandemic. The Swiss pharmaceutical company said it had 10 liters of vaccine that will be used in pre-clinical studies and clinical trials may be the beginning. The company uses cells to grow the vaccine virus and claims that this traditional overproduction with eggs "shows significant time savings." Thirty governments "requests" to the company for the ingredients of vaccines. If all goes well, the company expects to receive regulatory approval for its vaccine in the fall.
Novartis Reports Advance in swine flu vaccine production
Novartis Reports Advance in swine flu vaccine production -
0 Komentar